• 1301 Citations
  • 16 h-Index
20052019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • Ph.D., National Taiwan University

Research Interests

  • Tumor Biology
  • microRNA
  • Molecular cancer therapeutics

Experience

  • 2012/07~present Assistant Professor, Department of Medical Laboratory Science and Biotechnology, National Cheng-Kung University
  • 2010/08 - 2012/07Postdoctoral Fellow, Department of Oncology, College of Medicine, National Taiwan University
  • 2009/02 - 2010/07 Postdoctoral Fellow, Genomic Research Center, College of Medicine, National Taiwan University

Fingerprint Dive into the research topics where Pai-Sheng Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells

Lin, T. Y., Chan, H. H., Chen, S. H., Sarvagalla, S., Chen, P. S., Coumar, M. S., Cheng, S. M., Chang, Y. C., Lin, C. H., Leung, E. & Cheung, C. H. A., 2019 Jan 1, (Accepted/In press) In : Autophagy.

Research output: Contribution to journalReview article

Open Access
  • 3 Citations (Scopus)

    Mutation of the PTCH1 gene predicts recurrence of breast cancer

    Wang, C. Y., Chang, Y. C., Kuo, Y. L., Lee, K. T., Chen, P. S., Cheung, C. H. A., Chang, C. P., Phan, N. N., Shen, M. R. & Hsu, H. P., 2019 Nov 8, In : Scientific reports. 9, 1, 1 p., 16359.

    Research output: Contribution to journalArticle

    Open Access
  • TARBP2-enhanced resistance during tamoxifen treatment in breast cancer

    Wang, M. Y., Huang, H. Y., Kuo, Y. L., Lo, C., Sun, H. Y., Lyu, Y. J., Chen, B. R., Li, J. N. & Chen, P. S., 2019 Feb, In : Cancers. 11, 2, 210.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Citations (Scopus)

    TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

    Lai, H. H., Li, C. W., Hong, C. C., Sun, H. Y., Chiu, C. F., Ou, D. L. & Chen, P. S., 2019 Apr, In : Molecular Oncology. 13, 4, p. 928-945 18 p.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Citations (Scopus)

    TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

    Lai, H., Li, C., Hong, C., Sun, H., Chiu, C., Ou, D. & Chen, P-S., 2019 Jan 18, In : Molecular Oncology.

    Research output: Contribution to journalArticle